^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

GC502

i
Other names: GC502, CD19/CD7-Targeting CAR-T, TruUCAR-enabled CD19/CD7 dual-directed allogeneic CAR-T cell therapy
Associations
Trials
Company:
AstraZeneca
Drug class:
CD19-targeted CAR-T immunotherapy, CD7-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials